Table 1.

Baseline Characteristics of Patients

Patient Number	Gender	Location	Body Mass Index	Nephrometry Score	T Stage	Margin Status	Pathology
1	F	R	35	4a	T1b	N	ccRCC
2	F	L	23	9x	T1a	N	ccRCC
3	M	L	33	6a	T1a	N	ccRCC
4	F	R	25	10ah	T1a	N	Chromo
5	M	L	30	7p	T1b	N	ccRCC
6	F	L	32	9p	T1a	N	ccRCC
7	M	L	27	8p	T1b	N	ccRCC
8	M	L	37	4p	T1a	N	ccRCC
9	M	R	34	8a	T1a	N	ccRCC
10	M	R	38	7p	T1a	N	ccRCC
11	M	L	30	6a	T1a	N	Muc
12	M	L	26	7a	T3a	N	Pap
13	F	L	62	8a	T1a	N	ccRCC
14	M	R	47	9a	T3a	N	ccRCC
15	M	L	35	7p	T1a	N	ccRCC

F, female; M, male; N, negative; P, positive; ccRCC, clear cell renal cell carcinoma; Chromo, chromophobe renal cell carcinoma, Pap, papillary renal cell carcinoma; Muc, mucinous tubular and spindle cell renal cell carcinoma.